About the FREEDOM-1 Clinical Trial
The FREEDOM-1 study (FCR001) is a phase III clinical trial is to learn more about whether an investigational cell therapy using stem cells can prevent the rejection of living donor kidney transplants without the need for lifelong anti-rejection medicine.
The Ohio State Wexner Medical Center is the only location in Ohio to offer this study to our kidney transplant candidates transplanted from a living kidney donor.
Learn more about FREEDOM-1 from principal investigator Todd Pesavento, MD:
Hear firsthand from a trial participant:
Gift of Lift: A Donor's Perspective
Gift of Freedom A Donor's Perspective:
